Salient

Salient: the FDA knows the drug is dangerous. It doesn't know your patients. When the FDA issues a drug-safety warning, nothing re-reads the charts of patients already exposed. Prescribing alerts only check the next script; retroactive panel review is manual pharmacy work that takes weeks. Six months after the FDA's citalopram warning, 40% of exposed VA patients were still on high doses. Salient is an agent that closes the gap in seconds: Claude turns the alert prose into computable criteria, deterministic code scans the panel (the LLM never picks the cohort), Claude adjudicates the candidates using the chart and the ambient transcript, every claim is cited and mechanically verified, and a clinician approves the drafted action. Demo case: her chart says PRN opioids. Her transcript says "most days is the honest answer." She's nine weeks pregnant. The conversation caught what the chart missed.